November 21, 2017 : DCMS #372

DISASTERS AVERTED — Near Miss Case Studies

Do You “Make Room” for Your Patients?

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

Aaron Vinik Part 3, Reversing Heart Disease

HOMERUN SLIDES — Great Clinical Presentation Highlights

Diabetes 2017 Part 2

CLINICAL GEMS — The Best from Diabetes Texts

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #100: Pathogenesis of nonalcoholic fatty liver disease (NAFLD) Part 2

MOST POPULAR ARTICLES OF THE MONTH

#1 Awareness of Type 3C Diabetes and Why It Is Misdiagnosed
#2 Type 1 Cured in Mice
#3 Vitamin D’s Role In Preventing Type 1 Diabetes

Last month, Bill, a cycling friend of mine, asked if I knew a good physician in the area. He was from Maine and this was the winter that he and his spouse were making their move to Florida permanent. My first choice was my own physician as he is a cyclist and I had previously done education classes in his office. I gave him the physician’s phone number and let him know to get the last appointment before lunch so Doc Ed could spend extra time with him. It was a good thing he did, because while they were talking about electronic shifting, my pal mentioned a couple of things that led the physician to realize that Bill was suffering from gout. Although he had expressed concern over the symptoms before, his former caregivers told him he was likely dehydrated.

This is a good example of why every patient needs a different approach.

This week’s Disaster Averted looks at how changing your normal routine with a patient can make a big difference.

Dave Joffe

Editor-in-chief

Female, 67 years of age, type 2 diabetes, class 2 diabetes, depression, hyperlipidemia, vitamin D deficiency plus more. Her A1C is 6.8% and her lipids are within goal. Her random glucose 2 hours after eating cookies was 118 today. Her glucose lowering meds are Trulicity, metformin, and Jardiance. She takes them as prescribed. Her endocrinologist recommended she meet with me. She refused until he recommended she see me the same day she was coming in to see another health care provider for her monthly infusion for another disease process to make getting here easier.

In part 3 of this Exclusive Interview, Dr. Aaron Vinik talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the hurdle of trying to reverse arteriosclerosis.

In this week’s Homerun Slides, a look at empagliflozin and the effects of SGLT-2 inhibitors.

Cause of NAFLD: obesity and abnormalities in adipose tissue. Although both NAFLD and the MetS can occur in nonobese subjects, the prevalence of NAFLD is markedly increased in obesity as is that of the MetS. In the third National Health and Nutrition Examination Survey (NHANES), the prevalence of NAFLD averaged 7.5% and 6.7% in normal-weight men and women but was 57 and 44% in persons with a body mass index (BMI) greater than 35 kgm−2.

Diabetes has long been divided into type 1 and type 2. But a third type has entered the mix — and we aren’t diagnosing it correctly.

Ralph DeFronzo and his researchers at UT Health at San Antonio announced that they have cured type 1 diabetes.

Vitamin D supplementation could possibly reduce the risk of type 1 diabetes in susceptible children.